CORDIS · VMS - Vaginal Microbiome Screening

Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare.

Code

VMS - Vaginal Microbiome Screening

Programme

HORIZON

Call

EIC Accelerator Open 2023 HORIZON-EIC-2023-ACCELERATOROPEN-01

Status

SIGNED

Period

2023-07-01 – 2025-06-30

Official data · CORDIS · synced 2026-10-21 03:40 · official record

Participants

Description

VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience with which STI, vaginal infections and HPV screening is undertaken. Daye has patented the proprietary protocol for DNA extraction from a tampon for PCR analysis, testing for 16 different factors at a time. VMS can be used to detect vaginal dysbiosis, HPV and STIs, like chlamydia, gonorrhea and trichomoniasis. Vaginal microbiome screening with VMS will unlock invaluable insights into our customers’ vaginal health. There’s a direct correlation between vaginal microbiome health and the likelihood of contracting an STI, developing a gynecological cancer, experiencing fertility and pregnancy challenges, as well as susceptibility to recurrent vaginal and urethral infections. Post screen, VMS will offer comprehensive aftercare, including prescriptions, doctor consultations, booking in-person visits, and vaginal microbiome enhancement plan with probiotics

Official data · CORDIS · synced 2026-10-21 03:40 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).